Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2016

Jun 6, 2016

31949_dirs_2016-06-06_d5f9d3d5-b462-4665-ae0a-d0443073ffee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-04-18

Reporting Person: Palti Yoram (Director, Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-04-18 Ordinary Shares M 147825 $0.17 Acquired 147825 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-04-18 Options to Buy Ordinary Shares $0.17 M 147825 Disposed 2016-12-25 Ordinary Shares (147825) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1671054 Indirect

Footnotes

F1: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

F2: Fully vested and exercisable.